Long-read sequencing bridges germline and somatic variant detection: a multi-modal approach for hereditary cancer diagnostics.
Single genetic test using long-read technology simultaneously detects inherited and acquired cancer mutations, potentially streamlining multi-step diagnostic workflows.
This study demonstrates that long-read sequencing technology can bridge germline and somatic variant detection in a single assay for hereditary cancer diagnostics, potentially streamlining current multi-assay workflows. Long-read-based phasing also resolves VUS interpretation challenges not addressable by standard short-read approaches.
What the study was
- Study design
- Multi-modal diagnostic validation study
- Population
- Patients undergoing hereditary cancer diagnostics
- Category
- Genomics/Precision Medicine
- Maturity
- Exploratory
- Journal
- Clinical & translational oncology
Why it surfaced
Long-read sequencing for integrated germline/somatic hereditary cancer diagnostics is an emerging approach with near-term clinical promise. Not yet practice-changing but strong exploratory validation study.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.